Billionaire Profile
Habil Khorakiwala
Global Rank
#2858

Image: Unsplash Contributor | Unsplash License | via Unsplash

Habil Khorakiwala

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.219B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
-0.46% (24h)
Age
83
Source
pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Habil Khorakiwala, an 83-year-old Indian pharmaceutical tycoon, is the founder and chairman of Wockhardt, a global leader in the healthcare industry. His estimated net worth is $0.71 billion. Khorakiwala's career, marked by his visionary leadership, began in 1967 when he transformed his father's Worli Chemical Works into Wockhardt. He is known for his commitment to research and development in the pharmaceutical sector, focusing on innovative treatments, particularly in antibiotics. Khorakiwala's achievements have garnered him numerous awards, including an Honorary Doctorate from Purdue University. He is also recognized for his philanthropic endeavors through the Wockhardt Foundation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Habil Khorakiwala was born in Bombay (now Mumbai), India, in 1942, into a Dawoodi Bohra family. His father, Fakhruddin T. Khorakiwala, was the founder of Akbarallys, India's first departmental store, and a former Sheriff of Mumbai. Khorakiwala graduated in pharmacy from L.M. College in Ahmedabad and obtained a Master's degree in Pharmaceutical Science from Purdue University. He later completed an Advanced Management Programme at Harvard Business School.

Rise to Success

Khorakiwala founded Wockhardt in 1967, transforming it into a multinational pharmaceutical and biotechnology firm. Under his leadership, Wockhardt became a major player in the pharmaceutical industry, with a presence in various countries and a workforce of over 7,000 employees. He spearheaded the company's focus on research and development, particularly in antibiotics, which led to several innovative products and patents.

Key Business Strategies

Khorakiwala emphasized a customer-centric approach, driving innovation and continuous improvement within Wockhardt. He expanded the company through strategic acquisitions and by venturing into biotechnology, making Wockhardt a pioneer in recombinant insulin production in Asia. Khorakiwala has been praised for his tenacity, vision, and ability to remain calm during crises, leading Wockhardt through challenges.

Philanthropy

Khorakiwala established the Wockhardt Foundation, committed to social welfare and healthcare initiatives. The foundation has impacted millions of lives through programs like the Mobile 1000 project, which offers primary healthcare in rural areas, and the Pronto Toilets program, which builds household toilets.

Career Milestones

1967

Founded Wockhardt

Founded Wockhardt Limited after taking over his father's Worli Chemical Works. It started as a small firm with only 20 employees, making over-the-counter drugs. Since then, Wockhardt Limited has grown into a multinational pharmaceutical and biotechnology firm with manufacturing facilities around the world and more than 7,000 employees.

2006-2007

President of FICCI

Served as the President of FICCI (Federation of Indian Chambers of Commerce & Industry).

2010

Honorary Doctorate

Received an Honorary Doctorate from Purdue University.

2014

Chancellor of Jamia Hamdard University

Appointed as the Chancellor of Jamia Hamdard University.

2024

Lifetime Achievement Award

Honored with the prestigious Lifetime Achievement Award at the 10th Integrated Health & Wellbeing (IHW) Summit.

Philanthropy & Social Impact

Healthcare and Social Welfare

Wockhardt Foundation

Undisclosed

Established the Wockhardt Foundation to focus on social welfare and healthcare initiatives.

Business Philosophy & Leadership

Notable Quotes

"The secret to success in research is no different from the secret of success in business. One sees what everyone sees. But, one must imagine what no one else does. It is all in the mind."

"We are on the threshold of a new phase in the development of the Indian pharmaceutical industry. For the Indian pharmaceutical and biotechnological industry, the best is yet to come!"

Leadership Principles

Customer Focus

Emphasizes a customer-centric approach in all business decisions and actions.

Vision and Innovation

Driven by a strong commitment to research and development to create innovative and affordable medicines.

Resilience

Maintains a calm and tenacious approach during challenging times, fostering resilience and problem-solving.